Skip to content

Added Conversational Hypnosis Reduced General Anesthesia Side Effects for Day Case Breast Surgery

Added Conversational Hypnosis Reduced General Anesthesia Side Effects for Day Case Breast Surgery: A Prospective Randomized Phase III Clinical Trial (HYPNOSEIN)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03253159
Acronym
HYPNOSEIN
Enrollment
150
Registered
2017-08-17
Start date
2014-09-30
Completion date
2017-02-22
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

Evaluate the impact of the support in reducing postoperative adverse events in particular on the pain but also on anxiety, comfort, nausea, vomiting, and fatigue.

Detailed description

Drug premedication with anxiolytics (benzodiazepine or equivalent) are usually prescribed to alleviate patient anxiety. However, alternative techniques, additional non-pharmacological, have proven effective in alleviating pain and anxiety perioperative. These techniques are retained relaxation therapy, reinsurance, breathing techniques and medical hypnosis as a technique of choice. Regarding medical hypnosis techniques, many studies have shown that performing a hypnotic technique performed perioperative could reduce the doses of anesthetics, postoperative pain, length of stay in the post room Interventional (SSPI) and a number of postoperative adverse effects. Among the various techniques of hypnosis that can be offered to patients in the perioperative, conversational hypnosis is to accompany the patient on admission to the block to realization of general anesthesia. This technique aims to suggest a pleasant environment and not anxiety. This study evaluate the impact of this support in reducing postoperative major adverse effects in particular on the pain but also on anxiety, comfort, nausea, vomiting, and fatigue.

Interventions

BEHAVIORALHypnosis

The conversational hypnosis (10-15 min) is standardized and performed just before intravenous general anesthesia induction in the operative room.

Sponsors

Institut du Cancer de Montpellier - Val d'Aurelle
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Hypnosis before intravenous anesthesia versus no preparation before intravenous anesthesia

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female \> 18 years * Patient with ASA\* score 1, 2, 3 * Minor Unilateral breast surgery indication (tumorectomy, lumpectomy, limited axillary node dissection, minor breast reconstruction…) * Day case surgery (ambulatory surgery - living Day0-Day1) * General anesthesia required * Written informed consent * French medical benefit

Exclusion criteria

* Age \< 18 years * Patient with ASA score \> 4; * Body mass index \< 15 or 45kg/T; * Major Surgery indication : mastectomy, bilateral surgery, full axillary dissection, major breast reconstruction * Patient refusing hypnosis * Psychic or mental Disorders * Chronic pain * Opiate therapeutic \> 3 months * Not ability to speak and read French language * Deaf and dumb patient * Under guardianship patient or guardianship

Design outcomes

Primary

MeasureTime frameDescription
Assessment of pain scalethrough study completion, an average of 5 yearPain intensity assessment

Secondary

MeasureTime frameDescription
Reduction of the pain using Visual Analogic Scalethrough study completion, an average of 5 yearReduction of the pain adverse postoperative outcome: Using Visual Analogic Scale (VAS \> 3/10)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026